Patterns of recurrence after curative-intent radiation for oligometastases confined to one organ

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 33, Issue 2, 2010, Pages 157-163

  Milano, Michael T ^a   Katz, Alan W ^a   Okunieff, Paul ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Oligometastases; Patterns of recurrence; Stereotactic body radiation therapy

Indexed keywords

ABDOMINAL CANCER; ABDOMINAL METASTASIS; ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER GROWTH; CANCER SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METASTASIS; OLIGOMETASTASIS; OVERALL SURVIVAL; PELVIS CANCER; PELVIS METASTASIS; RECURRENCE RISK; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; SURVIVAL TIME;

EID: 77951068469     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181979238     Document Type: Article

References (28)

1. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13:8-10.
2. Hellman S, Weichselbaum RR. Importance of local control in an era of systemic therapy. Nat Clin Pract Oncol. 2005;2:60-61.
3. Mehta N, Mauer AM, Hellman S, et al. Analysis of further disease progression in metastatic nonsmall cell lung cancer: implications for locoregional treatment. Int J Oncol. 2004;25:1677-1683.
4. Tait CR, Waterworth A, Loncaster J, et al. The oligometastatic state in breast cancer: hypothesis or reality. Breast. 2005;14:87-93.
5. Milano MT, Katz AW, Muhs AG, et al. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer. 2008;112:650-658.
6. Milano MT, Katz AW, Schell MC, et al. Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. In Press.
7. Bozzetti F, Doci R, Bignami P, et al. Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg. 1987;205:264-270.
8. Sugihara K, Hojo K, Moriya Y, et al. Pattern of recurrence after hepatic resection for colorectal metastases. Br J Surg. 1993;80:1032-1035.
9. Lise M, Bacchetti S, Da Pian P, et al. Patterns of recurrence after resection of colorectal liver metastases: prediction by models of outcome analysis. World J Surg. 2001;25:638-644.
10. Topal B, Kaufman L, Aerts R, et al. Patterns of failure following curative resection of colorectal liver metastases. Eur J Surg Oncol. 2003;29:248-253.
11. White RR, Avital I, Sofocleous CT, et al. Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis. J Gastrointest Surg. 2007;11:256-263.
12. Aloia TA, Vauthey JN, Loyer EM, et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 2006;141:460-466; discussion 466-467.
13. Kosari K, Gomes M, Hunter D, et al. Local, intrahepatic, and systemic recurrence patterns after radiofrequency ablation of hepatic malignancies. J Gastrointest Surg. 2002;6:255-263.
14. Ravikumar TS, Steele G Jr, Kane R, et al. Experimental and clinical observations on hepatic cryosurgery for colorectal metastases. Cancer Res. 1991;51:6323-6327.
15. Katz AW, Carey-Sampson M, Muhs AG, et al. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys. 2006;67:793-798.
16. O'Dell WG, Schell MC, Reynolds D, et al. Dose broadening due to target position variability during fractionated breath-held radiation therapy. Med Phys. 2002;29:1430-1437.
17. Okunieff P, Petersen AL, Philip A, et al. Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol. 2006;45:808-817.
18. Luna-Perez P, Rodriguez-Coria DF, Arroyo B, et al. The natural history of liver metastases from colorectal cancer. Arch Med Res. 1998;29:319-324.
19. Yan TD, Chiang G, Zhao J, et al. Lung metastases after liver resection or cryotherapy for hepatic metastasis from colorectal cancer-there is a difference! HPB (Oxford). 2006;8:124-131.
20. Fidler IJ. Seed and soil revisited: contribution of the organ microenvironment to cancer metastasis. Surg Oncol Clin N Am. 2001;10:257-269, vii-viiii.
21. Fidler IJ. The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nat Rev Cancer. 2003;3:453-458.
22. Minn AJ, Kang Y, Serganova I, et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest. 2005;115:44-55.
23. Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature. 2005;436:518-524.
24. Minn AJ, Gupta GP, Padua D, et al. Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci U S A. 2007;104:6740-6745.
25. Mimori K, Kataoka A, Yoshinaga K, et al. Identification of molecular markers for metastasis-related genes in primary breast cancer cells. Clin Exp Metastasis. 2005;22:59-67.
26. Gupta GP, Minn AJ, Kang Y, et al. Identifying site-specific metastasis genes and functions. Cold Spring Harb Symp Quant Biol. 2005;70:149-158.
27. Smid M, Wang Y, Klijn JG, et al. Genes associated with breast cancer metastatic to bone. J Clin Oncol. 2006;24:2261-2267.
28. Weigelt B, Glas AM, Wessels LF, et al. Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci U S A. 2003;100:15901-15905.